Dr. Igor Ivanovich Rybkin MD.,PHD.
Hematologist-Oncologist | Hematology & Oncology
2799 W Grand Blvd Henry Ford Health Sy Detroit MI, 48202About
Dr. Igor Rybkin is a hematologist oncologist practicing in Detroit, MI. Dr. Rybkin specializes in the diagnosis, treatment and prevention of blood diseases such as anemia, hemophilia, sickle-cell disease, leukemia and lymphoma. Hematologist Oncologists are also trained in the study of cancer and its attack on other organs.
Board Certification
Internal MedicineAmerican Board of Internal MedicineABIM
Provider Details
Expert Publications
Data provided by the National Library of Medicine- alpha(1A) adrenergic receptor induces eukaryotic initiation factor 4E-binding protein 1 phosphorylation via a Ca(2+)-dependent pathway independent of phosphatidylinositol 3-kinase/Akt.
- [A structural analysis of the myocardium in 2-month-old rats cultivated in vitro from the viewpoint of tissue homeostasis].
- Effect of restraint stress on food intake and body weight is determined by time of day.
- Effect of repeated stress on body weight and body composition of rats fed low- and high-fat diets.
Clinical Trials
- Study of AM0010 With Nivolumab Compared to Nivolumab Alone Second-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
- Study of AM0010 With Pembrolizumab Compared to Pembrolizumab Alone First-line Tx in Patients With Metastatic Non-Small Cell Lung Cancer
- eXalt3: Study Comparing X-396 (Ensartinib) to Crizotinib in ALK Positive Non-Small Cell Lung Cancer (NSCLC) Patients
- A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET Amplification
- Clinical Study of Oral cMET Inhibitor INC280 in Adult Patients With EGFR Wild-type Advanced Non-small Cell Lung Cancer
Treatments
- Lung Cancer
- Esophageal Cancer
- Colon Cancer
Dr. Igor Ivanovich Rybkin MD.,PHD.'s Practice location
Dr. Igor Ivanovich Rybkin MD.,PHD.'s reviews
Write ReviewPatient Experience with Dr. Rybkin
Recommended Articles
- Treatment Update for Hodgkin Lymphoma
Over time, research has uncovered ways of treating Hodgkin lymphoma (HL) to produce an 80% to 90% cure rate. For the remaining 10% to 20% who are either resistant to the primary treatment or have relapsed, their cancer can still be fatal.The standard care for those not yet cured has been a two-step...
- The Leukemia & Lymphoma Society to Expand Mission Against Blood Cancer
On July 19, 2017, the Leukemia & Lymphoma Society, or LLS, proclaimed that they would be expanding their initiative to beat acute myeloid leukemia. Referred to as "Beat AML Master Trial", the project aims to test new and innovative treatments for those suffering from AML. For more information...
- How is Multiple Myeloma Diagnosed?
Various tests are conducted for the diagnosis of multiple myeloma since one result of a laboratory test cannot diagnose it alone. A number of factors like the history, complete body check-up, diagnostic test reports and symptoms of the patient are taken into consideration to get a proper diagnosis...
- AstraZeneca Gains United States Approval for Lymphoma Drug
Some forms of lymphoma are rarer than others. Most people can recognize Hodgkin lymphoma, but mantle cell lymphoma will strike them as a surprise.Because it is so rare, there are not as many drugs specific to this form of cancer. One has recently been approved in the United States, by the Food and...
- Study Finds 3% of Pediatric Non-Hodgkin Lymphoma Cases Are Transplant Recipients
Lymphoma is a blood cancer that affects both children and adults.Lymphoma begins its growth in the lymphatic white blood cells of the lymph system. This system is a major warrior in fighting off infections and diseases. It is part of the body’s immunity team.The lymph system loops throughout the...
- Breaking News on the Treatment of Follicular Lymphoma
Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...
Nearby Providers
- Dr. Mitchell Ford Peabody D.O.12000 E 12 Mile Rd Warren MI 48093
- Dr. Tarik H. Hadid MD11900 E 12 MILE RD STE 308 WARREN MI 48093
- Dr. Zyad Kafri MD19229 Mack Ave Grosse Pointe Woods MI 48236
- Dr. Feroze A Momin MD7105 Allen Rd Allen Park MI 48101
- Dr. Manolo Magno M.D.3577 W 13 Mile Rd Royal Oak MI 48073
- Dr. Mirna Farhat MD1537 MONROE ST DEARBORN MI 48124